Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration
- 10 October 2008
- journal article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 8  (11) , 1645-1657
- https://doi.org/10.1517/14712598.8.11.1645
Abstract
Plasmid DNA vaccination combined with electroporation (EP) provides a promising approach for the prevention of infectious diseases and for cancer immunotherapy. This technology has been described as being effective in activating humoral and cellular immune response in the host as well as in enhancing expression of the encoded antigen. Several reports showed EP has adjuvant-like properties when combined with plasmid DNA injection although the effect in the absence of DNA has not been investigated. The aim of this study is to clarify whether the application of EP alone to the skeletal muscle is able to recruit and trigger cells involved in antigen presentation and immune response. Mouse skeletal muscle treated by EP were observed and processed for clinical, histological and immunohistochemistry analysis at different time points. We demonstrate that EP induces transient morphological changes in the muscle with early production of endogenous cytokines responsible for signalling danger at the local level. Moreover, it causes the recruitment of inflammatory cells independently of the DNA injection and the activation of a danger pro-inflammatory pathway, resulting in T-lymphocyte migration. Our data indicate EP by itself is able to recruit and trigger cells involved in antigen presentation and immune response; hence, the idea that EP has adjuvant-like properties owing to a moderate tissue injury and generation of a pro-inflammatory context with cytokine release that enhances the immune response. We suggest EP may be of practical use in clinical protocols, contributing to the development of DNA vaccination strategies.Keywords
This publication has 57 references indexed in Scilit:
- Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma modelBiochemical and Biophysical Research Communications, 2008
- DNA vaccines: precision tools for activating effective immunity against cancerNature Reviews Cancer, 2008
- Application of Electroporation Gene Therapy: Past, Current, and FuturePublished by Springer Nature ,2008
- Electroporation-based DNA immunisation: translation to the clinicExpert Opinion on Biological Therapy, 2007
- Gene expression profiles in skeletal muscle after gene electrotransferBMC Molecular Biology, 2007
- In vivo plasmid DNA electroporation resulted in transfection of satellite cells and lasting transgene expression in regenerated muscle fibersBiochemical and Biophysical Research Communications, 2005
- A comprehensive study of optimal conditions for naked plasmid DNA transfer into skeletal muscle by electroporationThe Journal of Gene Medicine, 2005
- Early events of electroporationâmediated intramuscular DNA vaccination potentiate Th1âdirected immune responsesThe Journal of Gene Medicine, 2005
- In vivo electroporation improves immune responses to DNA vaccination in sheepVaccine, 2004
- Dangerous liaisons: the role of âdangerâ signals in the immune response to gene therapyBlood, 2002